Wuxi factory was completed last year, and Yakult in Shanghai was closed this year: The Shanghai factory has been integrated into the Shanghai headquarters. Recently, the news that Yakult, a lactic acid bacteria brand, closed its Shanghai factory attracted attention. It is reported that the Shanghai factory producing Yakult, a lactic acid bacteria beverage, stopped production on December 6, and the production will be fully transferred to other domestic bases such as Tianjin factory and Wuxi factory. In this regard, Yakult China said that the Shanghai factory has been integrated into the Shanghai headquarters, and the closure of the Shanghai factory is part of the business reform, with the aim of improving production efficiency through restructuring and integrating resource allocation to further improve sales and performance. (21 Finance)Canalys: It is estimated that the market size of generative AI will reach 72.8 billion dollars in 2029. According to Canalys' latest forecast, the global generative artificial intelligence (AI) market is still in its infancy, and it will grow fivefold in five years, from 14.6 billion dollars in 2024 to 72.8 billion dollars in 2029. Top applications include consumer, corporate services, retail, media and entertainment, and health care.Chip heavyweights continued to fall in the afternoon, with Zhongwei diving down more than 5%, Haiguang Information down more than 4%, and SMIC and North Huachuang down more than 1%.
The Shanghai Composite Index opened at 3,430.08 points in the afternoon, up 0.22%. The Shanghai and Shenzhen 300 Index opened at 3,993.87 points in the afternoon, down 0.04%. Shenzhen Component Index opened at 10,860.99 points in the afternoon, up 0.45%. The GEM index opened at 2,266.24 points in the afternoon, up 0.10%. Small and medium-sized board opened at 11,727.56 points in the afternoon, up 0.65%.Ice and snow tourism concept stocks strengthened in the short-term, with Inpais trading daily, Yuanlongyatu and Longjiang traffic rising.Musk said that if Tesla becomes the world's number one market value, Bill Gates will go bankrupt. Elon Musk wrote on the X platform that if Tesla's share price continues to rise to a certain level, the global shorts will be eliminated, even including Bill Gates, once the richest man in the world. Musk said: "If Tesla does become the most valuable company in the world so far, then short positions will bankrupt Bill Gates."
Hang Seng Index fell 0.2%, led by Meituan. The Hang Seng Index fell 0.2% to 20,278.66 in Hong Kong for two consecutive days. Meituan dragged down the index the most, falling by 1.7%. Chuangke Industrial Co., Ltd. suffered the biggest decline, falling by 4.1%. In midday trading, 33 of the 83 stocks fell and 46 rose; Three of the four stocks fell, led by industrial and commercial stocks.Chip heavyweights continued to fall in the afternoon, with Zhongwei diving down more than 5%, Haiguang Information down more than 4%, and SMIC and North Huachuang down more than 1%.The global layout will further promote Sannuo Bio-CGM products to enter the European market. Recently, Sannuo Bio-CGM has reached a strategic cooperation with A.Menarini Diagnostics, a leading European medical diagnosis company, and signed an exclusive distribution agreement. The continuous glucose monitoring (CGM) products of Sannuo Bio will be launched in the European market in the form of joint brands of both parties. Sannuo Bio authorized A.Menarini Diagnostics to exclusively sell its CGM products in more than 20 countries and regions in Europe. In the future, the latter will vigorously promote the access, promotion and sales of Sannuo Bio CGM products in the European medical insurance market. Sannuo Bio has been actively deploying its internationalization strategy since its listing, and its iCan CGM is the first continuous glucose monitoring product certified by CE MDR in China. At present, Europe is the second largest market for CGM. In this cooperation, the two sides signed an exclusive distribution contract with considerable volume, which is expected to greatly accelerate the penetration and coverage of Sannuo Bio-CGM products in the European market.
Strategy guide 12-13
Strategy guide
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13